Abstract:As deaths from acute myocardial infarction have declined dramatically over the past several decades, more and more patients survive with chronic myocardial ischemia.1,2 Hearts of most patients who survive acute myocardial infarction undergo remodeling. Hearts of most patients with sustained hypertension, another common cardiovascular disease, also show some degree of remodeling. The heart consists of 3 primary cell types: cardiomyocytes, fibroblasts, and endothelial cells. Myocytes occupy 75% of cardiac mass, generate the electric impulses, and induce cardiac contraction. Fibroblasts are primarily responsible for the maintenance of extracellular matrix (ECM) that is composed of collagens, fibronectins, elastins, fibrillins, and several other proteins. The capillary microcirculation network composed primarily of endothelial cells that serves the contractile assembly.3 In state of health, renin–angiotensin–aldosterone system is thought to be responsible for sustenance of cardiomyocyte, fibroblast, and endothelial cell biology. However, renin–angiotensin–aldosterone system activation leads to profound changes in cell biology during sustained hypoxia. Cardiomyocytes in the regions adjacent to ischemic area become large to maintain cardiac contraction. Fibroblasts around the cardiomyocytes begin to grow and differentiate into myofibroblasts to compensate for low-cardiac output. This process of cardiomyocyte hypertrophy and cardiac fibroblast growth is commonly known as cardiac remodeling.4–6 Release of large amounts of reactive oxygen species in the ischemic myocardium and the associated inflammatory response are thought to be mechanistic contributors to cardiac remodeling. Local activation of renin–angiotensin–aldosterone system contributes to further reactive oxygen species generation and release of transforming growth factor-β (TGF-β); the latter plays a central role in fibroblast transformation into myofibroblasts and subsequent activation of matrix metalloproteinases (MMPs), tissue inhibitors of metalloproteinases (TIMPs), and synthesis of collagens.7 MMPs and TIMPs mediate the balance between formation of collagens and their degradation, and their abnormal expression promotes secretion of large amounts of collagens by rapidly …

Matrix Metalloproteinases and Their Effects in Myocardial Fibrosis

Matrix metalloproteinases involvement in pathologic conditions

Extracellular matrix remodeling and cardiac fibrosis

Matrix metalloproteinase-9 induces cardiac fibroblast migration, collagen and cytokine secretion: Inhibition by salvianolic acid B from Salvia miltiorrhiza

Cathepsin S-mediated Fibroblast Trans-Differentiation Contributes to Left Ventricular Remodelling after Myocardial Infarction.

Cardiac Fibrosis: New Insights into the Pathogenesis

Tissue Inhibitor of Matrix Metalloproteinase-1 Promotes Myocardial Fibrosis by Mediating CD63–Integrin Β1 Interaction

Extracellular Matrix Protein-1 as a Mediator of Inflammation-Induced Fibrosis After Myocardial Infarction

Matrix Metalloproteinase and Its Inhibitors in Pathogenesis of Post-infarction Ventricular Remodeling

Substrate Stiffness-Regulated Matrix Metalloproteinase Output in Myocardial Cells and Cardiac Fibroblasts: Implications for Myocardial Fibrosis.

Myocardial fibrosis from the perspective of the extracellular matrix: mechanisms to clinical impact

Biochemical insights into the role of matrix metalloproteinases in regeneration: challenges and recent developments

The role of matrix metalloproteinase 9 in fibrosis diseases and its molecular mechanisms

Roleof Matrix Metalloproteinases in Myocardial Ischemia-Reperfusion Injury

Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Extracellular Matrix Remodeling during Left Ventricular Diastolic Dysfunction and Heart Failure with Preserved Ejection Fraction: A Systematic Review and Meta-Analysis

Tissue inhibitor of metalloproteinase-1 and -3 improves cardiac function in an ischemic cardiomyopathy model rat

The Roles of a Matricellular CCN Family Protein CCN5 in Cardiac Fibrosis of Heart Failure

Myocardial fibrosis in right heart dysfunction

Matrix Metalloproteinases: Inflammatory Regulators of Cell Behaviors in Vascular Formation and Remodeling

Metalloproteinases and Their Inhibitors: Potential for the Development of New Therapeutics

MicroRNAs Involved in the Regulation of Postischemic Cardiac Fibrosis